10-Q: 1606 Corp. Reports Third Quarter 2024 Results with Increased Net Loss and Focus on AI Chatbot Technology

1606 Corp. reported a significant increase in net loss for the third quarter of 2024, driven by higher operating expenses, while focusing on the development and commercialization of its AI chatbot technology.

Summary

• 1606 Corp. reported a net loss of $3,569,636 for the three months ended September 30, 2024, compared to a net loss of $566,308 for the same period in 2023.
• The company's operating expenses increased significantly to $3,246,179 in the third quarter of 2024, primarily due to $2.99 million in stock-based compensation.
• Revenue for the three months ended September 30, 2024 was $0, compared to $78 in the same period of 2023.
• For the nine months ended September 30, 2024, the net loss was $4,195,265, compared to $1,392,683 for the same period in 2023.
• The company's total operating expenses for the nine months ended September 30, 2024 were $3,932,839, which included approximately $3 million in stock-based compensation.
• Revenue for the nine months ended September 30, 2024 was $7,195, compared to $1,553 for the same period in 2023, with the company ceasing CBD product sales.
• The company had a gross loss of $118 for the nine months ended September 30, 2024, compared to a gross loss of $3,228 for the same period in 2023.
• As of September 30, 2024, the company had $26,782 in cash and a total deficit of $2,095,946.
• The company's current liabilities totaled $2,139,755, exceeding its total assets of $43,809.
• The company is focused on developing and commercializing AI chatbot technology for the CBD industry and public companies.

Sentiment

Score: 2

Explanation: The document indicates a very negative sentiment due to the company's significant net losses, minimal revenue, weak cash position, high debt, and material weaknesses in internal controls. The company's future is highly uncertain and dependent on its ability to raise capital and achieve profitability.

Positives

• The company is actively developing and commercializing AI chatbot technology, which could provide a recurring revenue stream.
• 1606 Corp. has partnered with Cool Blue Distribution to expand its CBD expertise and access to retailers.
• The company has completed its second AI bot for public companies, expanding its potential market.
• The company has a nonbinding LOI to acquire a stake in an AI company focused on drug discovery, which could be a strategic move.

Negatives

• The company's net loss has increased significantly, indicating financial instability.
• Operating expenses are very high, primarily due to stock-based compensation.
• Revenue is minimal, and the company has ceased sales of CBD products.
• The company's cash position is very weak, raising concerns about its ability to continue operations.
• The company's liabilities significantly exceed its assets, indicating a high level of financial risk.
• The company has a significant amount of debt, including convertible notes and a note payable to a related party.
• The company has identified material weaknesses in its internal controls over financial reporting.

Risks

• The company's ability to continue as a going concern is dependent on its ability to raise capital and achieve profitable operations.
• The company's high level of debt and low cash reserves pose a significant risk to its financial stability.
• The company's reliance on stock-based compensation may dilute shareholder value.
• The company's lack of revenue and high operating expenses may make it difficult to achieve profitability.
• The company's material weaknesses in internal controls over financial reporting could lead to misstatements in its financial statements.
• The company's dependence on external financing through convertible notes and debt instruments may lead to further dilution or financial strain.
• The company's ability to successfully commercialize its AI chatbot technology is uncertain.

Future Outlook

The company plans to continue developing and commercializing its AI chatbot technology and may need to raise additional capital to sustain operations. The company anticipates a cash need of approximately $1,000,000 over the next 12 months.

Management Comments

• Management believes the assumptions made to carve out the company's standalone financial statements from the consolidated Singlepoint results prior to the April 2021 spin-off are reasonable.
• Management will continue to pursue additional equity financing through private placements of the company's common stock.
• Management is focused on signing businesses to use the chatbot with a monthly recurring licensing fee model.
• Management believes that they have adequate provisions for any probable and estimable losses from legal proceedings.

Industry Context

The company's focus on AI chatbot technology aligns with the growing trend of using AI in various industries, including retail and investor relations. The company's initial focus on the CBD industry is a niche market, while its expansion into public companies broadens its potential customer base. The strategic investment in Adnexus could position the company in the growing field of AI in drug discovery.

Comparison to Industry Standards

• The company's financial performance is significantly below industry standards for technology companies, particularly in terms of revenue generation and profitability.
• The company's high operating expenses, driven by stock-based compensation, are not typical for early-stage technology companies.
• The company's reliance on convertible notes and debt financing is common for early-stage companies, but the high level of debt and low cash reserves are concerning.
• The company's lack of revenue and high operating expenses are not comparable to established AI chatbot companies such as LivePerson or Drift, which have significant revenue streams and established customer bases.
• The company's strategic investment in Adnexus is similar to other technology companies that are diversifying their offerings through acquisitions or investments in related fields, but the success of this investment is yet to be determined.
• The company's internal control weaknesses are not typical for publicly traded companies and indicate a need for significant improvements in governance and financial reporting.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in various lawsuits and legal proceedings arising in the ordinary course of business.
• The company believes it has adequate provisions for any probable and estimable losses from legal proceedings.
• The company acknowledges that an adverse result in legal matters may harm its business.

Related Party Transactions

• 4,040,000 shares of Class A convertible preferred stock were issued to board members for services.
• 90 shares of Series B convertible preferred stock were issued to the CEO and former CEO for services.
• The company has a note payable to a related party from an asset purchase agreement with Singlepoint.
• The company borrowed $270,000 from its former CEO in exchange for a promissory note.

Stakeholder Impact

• Shareholders are at risk due to the company's significant net losses, weak cash position, and high debt.
• Employees may be impacted by the company's financial instability and potential need for cost-cutting measures.
• Customers may be affected by the company's ability to continue operations and provide services.
• Suppliers and creditors face increased risk due to the company's financial difficulties.
• The company's ability to raise capital may be impacted by its poor financial performance.

Next Steps

• The company will continue to develop and commercialize its AI chatbot technology.
• The company will focus on signing businesses to use the chatbot with a monthly recurring licensing fee model.
• The company will pursue additional equity financing through private placements of its common stock.
• The company will work to address the material weaknesses in its internal controls over financial reporting.

Key Dates

Keywords

AI Chatbot, Artificial Intelligence, CBD Industry, Public Companies, Financial Results, Net Loss, Operating Expenses, Convertible Notes, Stock-Based Compensation, Going Concern, Debt, Internal Controls